Alcohol study discarded by Trump officials is published in scientific journal
A government-commissioned study had been meant to inform new dietary guidelines, and found risks associated with even light drinking.
Read full article →Healthcare Policy
Latest Healthcare Policy news from across the web.
More Americans survive cancer. But the psychological impacts can persist for years
Due to advancements in treatment and screening, more Americans are surviving cancer. But many are left with lingering mental health challenges like anxiety and depression.
Read full article →GLP-1s appear to protect against cancer. Researchers are trying to figure out how
Recent studies suggest GLP-1s, the weight loss and diabetes drugs, may both prevent cancer and slow its progression. While weight loss is known to curb cancer risks, GLP-1s may act on other brain and metabolic pathways to prevent cancer.
Read full article →Health workers at the epicenter of Congo’s Ebola outbreak labor with little pay or rest
Health workers at the epicenter of Congo's Ebola outbreak are laboring with little pay or rest.
Read full article →STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials
AstraZeneca’s GLP-1 pill showed promise in mid-stage obesity and diabetes studies, but it may still be too early to determine how it stacks up against other oral treatments.
Read full article →Ebola cases rise in Congo, as government revives travel restrictions
The Democratic Republic of Congo's Ebola outbreak is spreading at an unprecedented pace, Africa CDC warns.
Read full article →STAT+: UnitedHealthcare’s lactation billing feud, and fake strokes
The biggest U.S. health insurer is changing how it pays for lactation counseling, and it could cut payment for many providers.
Read full article →STAT+: Novo underwhelmed by drug it once fought Pfizer for
Revolution and Tango yield promising cancer results, Incyte buys bleeding disorder drug, and more biotech news
Read full article →STAT+: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more
Lilly disclosed new data that provide more details on the safety and tolerability of its next-generation obesity drug retatrutide
Read full article →STAT+: J&J spends $1 billion to enter KRAS race for cancer treatments
Johnson & Johnson said it will purchase the startup Firefly Bio for $1 billion in an effort to expand its work in the suddenly buzzy field of KRAS inhibitors.
Read full article →Major readouts from the annual diabetes conference
Why "Schedule F" matters, the Ebola outbreak response, and more health news from Morning Rounds
Read full article →STAT+: Combination of pancreatic cancer drugs from Tango, Revolution leads to high response rate
A combination of pancreatic cancer drugs from Tango Therapeutics and Revolution Medicines led to a strong response rate in an early-stage trial.
Read full article →